Neuropathix, Inc. Highlights Revenue Related to its Grant Award with NIH-NINDS
May 25, 2022
Healthcare
-
-
Daxor’s Blood Volume Analyzer (BVA-100®) To Be Used As a Key Metric in Study of “Long Hauler” COVID-19 Patients
May 25, 2022
-
AXIM Biotechnologies Completes Optimization of Only FDA-Cleared IgE Rapid Diagnostics Test – In-House Manufacturing Lowers Cost and Eliminates Supply Chain Expenditures
May 24, 2022
-
22nd Century Group (Nasdaq: XXII) Announces John J. Miller Joins Its Tobacco Business
May 23, 2022
-
Nemaura Medical Strengthens Balance Sheet with Further Non-Dilutive Funding
May 23, 2022
-
22nd Century Group (Nasdaq: XXII) Begins Integration of GVB Biopharma, Creating a Complete, Robust Hemp/Cannabis Platform
May 18, 2022
-
Can B Corp. Reports First Quarter Revenue Growth of 606% to $1.9 Million, the Highest Quarterly Revenue in Company History
May 18, 2022
-
MySugarWatch Continues Large-Scale Awareness Campaign Around Nemaura Medical’s sugarBEAT Non-Invasive Continuous Glucose Monitor Commencing Direct-to-Consumer Campaign in Daily Mail
May 17, 2022
-
Petros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 16, 2022
-
22nd Century Group (Nasdaq: XXII) Acquires GVB Biopharma, a Leading Hemp/Cannabis Company
May 13, 2022
-
Alkaline88® 1-Liter 12-Pack Will Be Available in Approximately 8,000 Stores of America’s Largest Drugstore Chain
May 10, 2022
-
AXIM Biotechnologies Develops Novel Tear Sample Collector System, Files Patent Application
May 10, 2022
-
Augmedix Reports First Quarter 2022 Financial Results
May 9, 2022
-
Aegis Capital Corp. acted as Sole Bookrunner on a $5 Million Underwritten Public Offering for The Alkaline Water Company Inc. (NASDAQ: WTER)
May 9, 2022
-
The Alkaline Water Company Announces Closing of Public Offering of Common Stock
May 9, 2022
-
Biotricity Issues Shareholder Update
May 5, 2022